NAD+ Research Guide: Cellular Energy, Sirtuin Biology, and the Science of Aging

By Justin Cartier

This compound is covered in our overview of anti-aging and longevity peptides.

NAD+ is a small molecule your cells can’t make energy or repair DNA without. The catch is that levels slide as we age. Published work shows the cofactor falling across most tissues during aging, and that decline is exactly why it sits at the center of longevity science.^[1]

This article is for research and educational use only. NAD+ and its precursors are research compounds, not medicines, and aren’t for human use unless sold as an approved supplement.

You don’t eat it directly in any real amount. Your body builds it from vitamin B3 through two main routes: a “de novo” path from the amino acid tryptophan, and a “salvage” path that recycles a form called nicotinamide back into the finished cofactor. The two precursors researchers study most, nicotinamide riboside (NR) and nicotinamide mononucleotide (NMN), slot into the salvage pathway at different points. This guide covers what the molecule does in the cell, how it’s made, what the research shows on sirtuins, mitochondria, and aging, how the precursors stack up, and what to weigh when planning research.

What does NAD do for the body?

It does two main jobs in the cell, and the first one is energy: it shuttles electrons inside the mitochondrion, flipping between NAD+ and NADH to help generate ATP, the cell’s energy currency. The second job is fuel for enzymes, because three different sets of them burn through it: the sirtuins, which steer gene activity, the PARPs, which repair DNA, and CD38. Supplements are really just trying to hand those enzymes more fuel. Imai and Guarente, in Trends in Cell Biology, lay out how levels fall during aging across most mammalian tissues, tracking right alongside metabolic decline.^[1]

One result made the field sit up. Gomes and colleagues, writing in Cell, showed that raising the cofactor in old mice pulled mitochondrial function back toward that of a young animal within a few weeks, with better muscle endurance and gene activity.^[2] That’s not broad “anti-aging.” It’s a specific restoring of one kind of cell function.

How is NAD made in the body?

Three routes feed the pool. There’s the de novo route from tryptophan, which is minor. There’s the Preiss-Handler route from nicotinic acid, a form of vitamin B3. And there’s the salvage route from nicotinamide, which does most of the work in most tissues. An enzyme called NAMPT sets the pace of that salvage pathway. NMN is a step inside it; NR enters one step earlier. Both are widely used as oral precursors, and both feed the same NAD biosynthesis machinery.

Sirtuin activation and DNA repair

Sirtuins are enzymes that simply can’t run without NAD+. They help control genes, repair DNA, and manage metabolism. SIRT1 works in the cytoplasm and nucleus, SIRT3, 4, and 5 work in mitochondria, and SIRT6 and SIRT7 work in the nucleus. Kanfi and colleagues, in Nature, found that male mice engineered to make extra SIRT6 outlived normal mice, which is direct genetic evidence that sirtuin activity can move the needle on lifespan.^[3]

PARP enzymes draw on the same pool whenever they repair DNA damage, and that sets up a trap as tissue ages: the constant DNA damage steadily drains the available supply, which in turn starves the sirtuins, which makes the underlying damage worse still. It becomes a vicious cycle that feeds on itself. Topping up the pool helps both ends at once: more fuel for PARP repair, more fuel for sirtuin gene control.

Age-related NAD decline and CD38

The age-related decline has at least three causes: less NAMPT in old tissue, heavier PARP use from accumulating DNA damage, and rising CD38 activity. Camacho-Pereira and colleagues, in Cell Metabolism, showed the NAD-consuming enzyme CD38 climbs with age, adding a third drain on the pool.^[4] That’s why CD38 blockers are now studied as a partner to the precursors rather than a rival.

NMN and NR: do precursors raise NAD?

They do, though how well depends on the tissue. De Picciotto and colleagues, in Aging Cell, showed that giving NMN to aged mouse blood vessels lifted NAD+, improved vessel function, and cut oxidative stress.^[5] NR takes a different transport route but raises liver and blood levels by similar amounts across animal and human studies.

How much oral NMN actually gets absorbed is still argued over. Some studies report 30 to 50 percent; others put it lower, because a chunk gets broken down in the gut first. Direct NAD+ by IV sidesteps that question, but it’s harder to administer and clears from the blood fast.

Is NAD just vitamin B3?

It’s what your body builds from vitamin B3, but it isn’t the same thing. Vitamin B3, meaning niacin and its forms, is the raw material. NAD+ is the active, finished cofactor. Plain niacin does nudge levels up a little in most tissues, but it has limits: high doses cause flushing, and it may not convert well in aged tissue where NAMPT runs low. The newer options, NMN, NR, and direct NAD+, get around that NAMPT bottleneck and lift levels more per dose.

Is NAD like Ozempic?

Not even close, despite how often the two end up mentioned in the same breath. NAD+ is a small-molecule cell cofactor, whereas Ozempic, or semaglutide, is a GLP-1 receptor peptide, and they work in completely different ways. The cofactor supports mitochondrial energy and sirtuin and PARP activity all over the cell, while semaglutide acts on GLP-1 receptors in the pancreas and the brain’s appetite centers. One works slowly, shifting cellular energy over weeks. The other cuts appetite and drives real weight loss within months. And NAD+ is something your own body makes, where semaglutide is a synthetic peptide built in a lab. The two don’t compete. They answer different metabolic questions.

Can NAD reverse aging?

It can reverse some aging-related declines, but not aging itself. In rodent studies, steady dosing improves mitochondrial function, insulin sensitivity, and exercise capacity, yet the gains fade once dosing stops. It targets one slice of aging, the NAD-dependent part, and leaves DNA, telomere, and epigenetic aging untouched. “Reverse aging” oversells the data. “Restore NAD-dependent cell function in aged tissue” is the honest version.

Benefits of NAD+ therapy

The benefits reported in rodent and small human research cluster in a handful of areas. Aged muscle shows better mitochondrial function, with measurable endurance gains. Insulin sensitivity improves in pre-diabetic and metabolic-syndrome groups. Cell-energy markers rise in blood cells and other easy-to-sample tissues. Early-aging human groups post modest gains in thinking, the heart and blood vessels show better function, and a few cosmetic studies report skin benefits. The honest caveat: in most of this work the effects are modest, often a few percent on a given measure, and they need continued dosing. This isn’t a fast-acting fix.

How to increase NAD levels naturally

A few habits raise your own supply. Eating less, or time-restricted eating, pushes NAMPT up. Regular aerobic exercise raises muscle levels quickly. Good sleep matters too, because the body clock controls NAMPT’s daily cycling. Sun exposure bumps liver NAD+ through UV-driven PARP activity, but the DNA-damage cost makes that a bad trade. Vitamin B3 in foods like fish, meat, mushrooms, and peanuts keeps levels normal, though it won’t deliver the big jump that supplements can.

Potential side effects of boosting NAD

Reported side effects of the precursors are minimal. The usual ones are mild nausea or stomach upset with high-dose NMN, flushing with niacin-based forms, and rare shifts in the methylation pathway that can raise homocysteine. Direct IV NAD+ can bring brief flushing, chest pressure, and nausea during the infusion, all of which pass within hours. Long-term safety looks good, but it only covers a few years of human use so far.

Consistency between lots is everything, so order research peptides in Canada where every batch is mass-spec verified.

Legal status and sourcing

NAD+ and its precursors NMN and NR are sold as research chemicals, and some forms of NR are also sold as dietary supplements. For how the rules work where these are bought, see our guide to buying peptides in Canada. Direct IV NAD+ shows up in some wellness clinics, but it isn’t cleared by Health Canada or the FDA for any specific treatment, and none of these molecules sit on the World Anti-Doping Agency banned list.

When a new NAD+ lot reaches my bench, I log the lot number and pull its Certificate of Analysis (COA), the lab report shipped with the vial. I check the mass on that COA against the expected molecular weight, so I know the vial holds real NAD+, then read the HPLC trace (a purity test that splits the sample into peaks) and confirm one clean peak at high purity before anything gets used. View the NAD+ product page.

NAD+ questions

What does NAD do for the body?

It carries electrons for mitochondrial energy, fuels the sirtuins that control aging-related genes, and supports PARP DNA repair. Supplements aim to give the sirtuins and PARPs more fuel.

Is NAD like Ozempic?

No. NAD+ is a small-molecule cell cofactor; Ozempic, or semaglutide, is a GLP-1 receptor peptide. They work in completely different ways.

Can NAD reverse aging?

It reverses some NAD-dependent declines in aged rodents with ongoing dosing, but not DNA, telomere, or epigenetic aging. “Restore NAD-dependent function” is the accurate framing.

Is NAD just vitamin B3?

It’s built from vitamin B3, but the newer precursors, NMN and NR, get around the NAMPT bottleneck that limits B3 conversion in aged tissue and raise levels more per dose.

What are the benefits of NAD supplements or therapy?

Better mitochondrial function in aged tissue, better insulin sensitivity, better cell-energy markers, modest thinking gains in early-aging groups, and heart benefits. The effects are modest and need continued dosing.

Key data point: in aged mice, restoring NAD+ brought mitochondrial function back toward that of young animals within weeks, showing the loss is a partly reversible part of aging biology.^[2]

Summary

NAD+ is a central cell cofactor, needed for mitochondrial energy, sirtuin and PARP activity, and DNA repair. Its levels fall sharply from young adulthood into late life, and that drop feeds age-related metabolic and mitochondrial trouble. Precursors like NMN and NR, along with direct NAD+, raise the cell’s pool and restore some aged-tissue function in rodent and small human studies. It isn’t a peptide, for the record; it’s a small-molecule cofactor. The effects are slow, modest, and dependent on continued dosing.

Sources: [1] NAD+ and sirtuins in aging and disease, PubMed. [2] Declining NAD+ and nuclear-mitochondrial communication in aging, PubMed. [3] SIRT6 regulates lifespan in male mice, PubMed. [4] CD38 drives age-related NAD decline, PubMed. [5] NMN reverses vascular dysfunction with aging in mice, PubMed.

Justin Cartier

The Reviv Peptides Research Team is a collective of science writers and researchers dedicated to producing evidence-based, peer-reviewed-grade content about research peptides. Our work focuses on molecular mechanisms, receptor pharmacology, and preclinical data — including GLP-1/GIP/glucagon incretin biology, growth hormone axis peptides (GHRH analogs and ghrelin-receptor secretagogues), mitochondrial-derived peptides (MOTS-c, SS-31), tissue-repair peptides (BPC-157, TB-500, GHK-Cu), and nootropic peptides (Semax, Selank). All content is written in a strict preclinical/laboratory context; none of our editorial material is intended as medical advice. Every guide is reviewed for scientific accuracy against published peer-reviewed literature.